Insulet (NASDAQ:PODD) PT Lowered to $244.00 at Morgan Stanley
Insulet (NASDAQ:PODD – Get Rating) had its price target cut by stock analysts at Morgan Stanley from $268.00 to $244.00 in a report released on Tuesday, Stock Target Advisor reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price would indicate a potential upside of 12.05% […]